Публикации

Название Скачать Размер
“Ведення побічних реакцій під час лікування хворих на туберкульоз та ко-інфекцію (туберкульоз/ВІЛ-інфекція/СНІД” Посібник для лікарів
320.27 KB
«Сводное руководство по использованию антиретровирусных препаратов для лечения и профилактики ВИЧ-инфекции: рекомендации с позиций общественного здравоохранения» 2-е издание. 2016
15.84 MB
2016 Hepatitis C Virus (HCV) Update
52.15 KB
2016 Pipeline Report – TB Edition Only
722.85 KB
2016 Pipeline Report Full
1.51 MB
90-90-90 An ambitious treatment target to help end the AIDS epidemic
959.67 KB
A guide to monitoring and evaluation for collaborative TBHIV activities.
898.16 KB
Abstract book. AIDS 2016. 21st international AIDS conference. 18 – 22 July 2016. Durban, South Africa.
16.73 MB
Access to medicines the role of intellectual property law and policy.
403.33 KB
Adolescents Living with HIV: Developing and Strengthening Care and Support Services
4.82 MB
Adoption of national recommendations related to use of antiretroviral therapy before and shortly following the launch of the 2013 WHO consolidated guidelines.
1.37 MB
AIDS by the numbers | UNAIDS | 2016
1.10 MB
AIDS diagnoses and rates per 100 000 population, by country and year of diagnosis (2005-2014).
76.29 KB
AIDS diagnoses in females and rates per 100 000 population, by country and year of diagnosis (2005-2014).
73.48 KB
AIDS diagnoses in males and rates per 100 000 population, by country and year of diagnosis (2005-2014).
74.04 KB
AIDS diagnoses in men infected through sex with men, by country and year of diagnosis (2005-2014).
51.81 KB
AIDS diagnoses in people infected through heterosexual contact, by country and year of diagnosis (2005-2014).
52.07 KB
AIDS diagnoses in people infected through injecting drug use, by country and year of diagnosis (2005-2014).
51.88 KB
AIDS diagnoses in people infected through mother to child transmission, by country and year of diagnosis (2005-2014).
51.28 KB
AIDS diagnoses, by sex, age and year of diagnosis (2005–2014) and cumulative totals.
98.90 KB
AIDS diagnoses, by sex, transmission mode and year of diagnosis (2005–2014) and cumulative totals.
98.29 KB
An analysis of 48 national HIV testing and counselling policies.
494.69 KB
Antiretroviral medicines in low-and middle-income countries forecasts of global and regional demand for 2013-2016.
1.70 MB
Antiretroviral priorities of the medicines patent pool
338.44 KB
API production capacity.
493.55 KB
ART in pictures. HIV treatment explained
1.26 MB
ART mapping Armenia 2014.
203.13 KB
ART mapping Belarus 2014.
99.00 KB
ART mapping Georgia 2014.
71.20 KB
ART mapping Kazakhstan 2014.
139.55 KB
ART mapping Kyrgyzstan 2014.
219.64 KB
ART mapping Moldova 2014.
211.74 KB
ART mapping Uzbekistan 2014.
75.66 KB
ART profile Tajikistan 2014.
207.93 KB
CHAI ARV pipeline forecast.
1.31 MB
Combined global demand forecasts for antiretroviral medicines and HIV diagnostics in low- and middle-income countries from 2015 to 2020
2.86 MB
Commentary antiretroviral therapy initiation criteria in low resource settings – from ‘when to start’ to ‘when not to start’.
70.51 KB
Commentary operational guidance in the 2013 WHO consolidated antiretroviral guidelines.
57.29 KB
Community and service provider views to inform the 2013 WHO consolidated antiretroviral guidelines key findings and lessons learn.
281.09 KB
Companion handbook to the WHO guidelines for the programmatic management of drug-resistant tuberculosis.
1.95 MB
Confronting discrimination: overcoming HIV-related stigma and discrimination in health-care settings and beyond
478.19 KB
Consolidated forecast of global ARV demand.
460.11 KB
Consolidated guideline on sexual and reproductive health and rights of women living with HIV
470.34 KB
Consolidated guideline on sexual and reproductive health and rights of women living with HIV
1.66 MB
Consolidated guidelines on HIV prevention, diagnosis, treatment and care for key populations – 2016 update.
5.48 MB
Consolidated guidelines on HIV testing services 5Cs consent, confidentiality, counselling, correct results and connection. 2015.
3.36 MB
Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. 2013.
2.48 MB
Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. 2015.
1.49 MB
Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. 2016. 2nd eddition
5.26 MB
Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. Art 2016.
5.97 MB
Deaths among AIDS cases, by geographic area, by country and year of death (2005-2014).
51.89 KB
Deaths among AIDS cases, by sex, transmission mode and year of death (2005–2014) and cumulative totals.
97.92 KB
Developing the 2013 WHO consolidated antiretroviral guidelines.
98.02 KB
Developing tuberculosis treatment services for people who use drugs. Trainer’s manual.
1.81 MB
Drug regulatory database.
582.23 KB
Dublin declaration HIV data evidence brief.
86.88 KB
Dublin declaration HIV prevention evidence brief.
148.81 KB
Dublin declaration HIV testing evidence brief.
153.65 KB
Dublin declaration HIV treatment evidence brief 2014.
443.00 KB
Dublin declaration monitoring report migrants september 2013.
5.76 MB
Dublin declaration. Thematic report men who have sex with men 2014.
951.67 KB
Dublin declaration. Thematic report people who inject drugs 2014.
1.28 MB
Dublin declaration. Thematic report prisoners 2014.
1.10 MB
Dublin declaration.Thematic report sex workers 2014.
1.07 MB
EACS guidelines 8.2 January 2017
1.06 MB
Eacs guidelines version 8.0 october 2015.
856.18 KB
Eacs guidelines version 8.1 October 2016
1.03 MB
Early initiation of antiretroviral therapy in HIV-infected adults and adolescents a systematic review.
374.03 KB
ENDING AIDS: PROGRESS TOWARDS THE 90–90–90 TARGETS
7.21 MB
Estimates of global, regional, and national incidence, prevalence, and mortality of HIV, 1980–2015 the global burden of disease study 2015.
12.91 MB
Ethics guidance for the implementation of the End TB strategy
1.20 MB
Fact sheet to the WHO consolidated guidelines on HIV testing services. 2015.
729.14 KB
FAST-TRACK AND HUMAN RIGHTS. Advancing human rights in efforts to accelerate the response to HIV
656.17 KB
Fast-track commitments to end AIDS by 2030.
53.55 KB
Fast-track update on investments needed in the AIDS responce. UNAIDS 2016. Reference.
748.10 KB
FHI key population program implementation guide 2016.
1.46 MB
FHI HIV cascade framework for key populations. October 2015.
1.33 MB
FIRST RESULTS OF THE FLASH! PREP IN EUROPE ONLINE SURVEY
963.58 KB
Fit for purpose Antiretroviral treatment optimisation for adults and children
579.96 KB
Fit for Purpose: Antiretroviral Treatment Optimization
184.72 KB
From Dublin to Rome. Ten years of responding to HIV in Europe and Central Asia.
876.09 KB
Full Report On Evolution Of Global Public Health 2007-2017
0.00 KB
Getting it right WHO guidance to diagnose correctly 90_ of people living with HIV.
1,002.72 KB
GETTING TO ZERO — GLOBAL SOCIAL WORK RESPONDS TO HIV
2.93 MB
GF procurement and funding.
3.19 MB
Global health sector strategy on HIV 2016–2021 towards ending AIDS.
4.68 MB
Global Health Sector Strategy On Viral Hepatitis 2016-2021. June 2016
4.71 MB
GPRM observed data adults.
1.52 MB
GPRM observed data pediatrics.
1.27 MB
Guide monitoring evaluation collaborative TB-HIV activities 2015.
898.19 KB
Guide to monitoring and evaluation of advocacy, communication, and social mobilization to support tuberculosis prevention and care.
613.55 KB
Guidelines for second generation HIV surveillance: an update: Know your epidemic.
2.00 MB
Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents
4.74 MB
Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents.
3.66 MB
Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection
7.18 MB
Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection (medication and dosage)
445.20 KB
Guidelines on HIV self-testing and partner notification Supplement to consolidated guidelines on HIV testing services. December 2016
4.77 MB
Handbook on monitoring and evaluation of human resources.
3.92 MB
HCV testing and linkage to care
187.90 KB
Hepatitis A outbreak in the EU/EEA mostly affecting men who have sex with men. Third update, 28 June 2017
262.28 KB
Hepatitis B and C testing activities, needs, and priorities in the EU/EEA. Technical report
1.43 MB
Hepatitis E in the EU/EEA, 2005–2015 Baseline assessment of testing, diagnosis, surveillance and epidemiology
4.14 MB
HIV 2015/2016
5.11 MB
HIV diagnoses in people infected through heterosexual contact in 2014.
61.68 KB
HIV diagnoses, by country of report and region of origin, cases diagnosed in 2014.
72.33 KB
HIV diagnoses, by transmission mode and country or subcontinent of origin, in cases reported in 2014.
71.54 KB
HIV drug resistance report 2017
4.97 MB
HIV in europ reg.
30.14 MB
HIV pipeline 2017: new drugs in development
522.05 KB
HIV Prevention 2020 Road Map
240.27 KB
HIV Prevention Research & Development Investments 2000–2016. Investment priorities to fund innovation in a challenging global health landscape
2.68 MB
HIV testing increasing uptake and effectiveness in the European Union.
864.39 KB
HIV-AIDS surveillance report 2014.
2.28 MB
HIV, HUMAN RIGHTS AND GENDER EQUALITY. Technical Brief
633.72 KB
How Civil Society and Communities Can Engage in the Global Fund Grant-making Processes. Information note
604.70 KB
How to advocate for community responses and systems strengthening interventions in Global Fund funding requests
750.54 KB
IATT optimal and limited use paed ARV formulary.
1.10 MB
Implications of the start study data 2015.
382.52 KB
Improving antiretroviral therapy scale-up and effectiveness through service integration and decentralization.
344.18 KB
Infographic. What are the ten global measurements for HIV epidemic.
37.56 KB
Integrated prevention services for HIV infection, viral hepatitis, sexually transmitted diseases, and tuberculosis for persons who use drugs illicitly.
977.20 KB
Integrating collaborative TB and HIV services within a comprehensive package of care for people who inject drugs.
1.16 MB
Integrating collaborative TB and HIV services within a comprehensive package of care for people who inject drugs.
1.16 MB
Integration of antiretroviral therapy with tuberculosis treatment.
637.11 KB
Intellectual properly and access to medicines
294.97 KB
Interventions to improve adherence to antiretroviral therapy a rapid systematic review.
274.43 KB
Invest in HIV prevention.
633.67 KB
INVESTING IN COMMUNITY RESPONSES A CASE FOR FUNDING NON-SERVICE DELIVERY COMMUNITY ACTIONS TO END AIDS
752.13 KB
IPU fast-tracking HIV treatment parliamentary action and policy options. 2015.
2.21 MB
Metrics for monitoring the cascade of HIV testing, care and treatment services in Asia and the Pacific.
3.55 MB
Monitoring HIV impact using population-based surveys.
5.42 MB
MPP forecasting model adults.
1.47 MB
MPP forecasting model paed.
693.55 KB
New HIV diagnoses and rates per 100 000 population, by country and year of diagnosis (2005-2014).
77.48 KB
New HIV diagnoses and rates per 100 000 population, by country and year of statistics (2005-2014).
74.87 KB
New HIV diagnoses in females and rates per 100 000 population, by country and year of diagnosis (2005-2014).
74.16 KB
New HIV diagnoses in males and rates per 100 000 population, by country and year of diagnosis (2005-2014).
74.62 KB
New HIV diagnoses in men infected through sex with men, by country and year of diagnosis (2005-2014).
52.38 KB
New HIV diagnoses in people infected through heterosexual contact, by country and year of diagnosis (2005-2014).
52.63 KB
New HIV diagnoses in people infected through injecting drug use, by country and year of diagnosis (2005-2014).
52.35 KB
New HIV diagnoses in people infected through mother-to-child transmission, by country and year of diagnosis (2005-2014).
61.68 KB
New HIV diagnoses, by country of report and probable region of infection, in 2014.
71.80 KB
New HIV diagnoses, by sex, age and year of diagnosis (2005–2014) and cumulative totals.
99.83 KB
New HIV diagnoses, by sex, transmission mode and year of diagnosis (2005–2014) and cumulative totals.
98.86 KB
New PQ financing strategy. Meeting with ARV manufacturers.
403.15 KB
Number of HIV tests performed, excluding unlinked anonymous testing and testing of blood donations.
52.70 KB
PEPFAR contribution to the scale up of ART.
909.52 KB
Percentage of new HIV diagnoses (2014) among people 14 years reported with information about CD4 cell count.
61.99 KB
Policy brief: WHO recommends HIV self-testing. 2016
534.05 KB
Prevention gap report 2016.
7.75 MB
Preventive Technologies: Antiretroviral and Vaccine Development
188.87 KB
Progress and challenges towards achieving the elimination of mother to child transmission of HIV and congenital syphilis in Europe and Central Asia. Consultation report. 2015.
994.11 KB
Reaching 90-90-90 goals together improving TB-HIV case finding through integration.
1.01 MB
Recommendations for Testing, Managing, and Treating Hepatitis C – April 12, 2017
1.46 MB
Regional Action Plan of Communities on Scale Up of Access to High Quality and Continuous HIV Care for all who needs it in the Region of Eastern Europe and Central Asia.
1.56 MB
Report of the tenth meeting of the European technical advisory group on tuberculosis control. 2015.
137.24 KB
Research Toward a Cure and Immune-Based and Gene Therapies
163.04 KB
Safety of efavirenz in the first trimester of pregnancy an updated systematic review and meta-analysis.
178.24 KB
Selection HIV tests.
227.12 KB
Services delivery approaches to HIV testing and counselling (HTC) a strategic HTC programme framework.
539.10 KB
Smart investments.
255.06 KB
Supplement to the 2013 consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection recommendations for a public health approach.
4.39 MB
Surveillance report. HIV – AIDS surveillance in Europe 2014.
11.99 MB
Systematic review on the diagnosis, treatment, care and prevention of tuberculosis in prison settings
2.61 MB
Table KAP prevalence among key populations.
17.35 KB
TAG Pipeline Report – 2017
774.66 KB
The Antiretroviral Pipeline
178.36 KB
THE ANTIRETROVIRAL PIPELINE Executive Summary – HIV By Mark Harrington
442.12 KB
The impact and cost of the 2013 WHO recommendations on eligibility for antiretroviral therapy.
142.05 KB
The most common AIDS-indicative diseases diagnosed in 2014, ordered by frequency.
61.20 KB
The Pediatric Antiretroviral Pipeline
144.21 KB
The Pediatric Tuberculosis Treatment Pipeline
0.00 KB
The role of intellectual property in local production in developing countries. Opportunities and challenges
820.95 KB
The Tuberculosis Diagnostics Pipeline
134.67 KB
The Tuberculosis Prevention Pipeline
154.96 KB
The Tuberculosis Treatment Pipeline
146.76 KB
Thematic report HIV continuum of care. Monitoring implementation of the Dublin declaration on partnership to fight HIV-AIDS in Europe and Central Asia 2014.
800.05 KB
To the 2013 consolidated guidelines on the use of antiretroviral drigs for treating and preventing HIV infection.
4.41 MB
TRAINING MANUAL FOR PATIENT ADVOCATES AND ORGANISATIONS AFFORDABILITY OF MEDICINES AND DIAGNOSTICS
1.37 MB
TUBERCULOSIS Diagnostics Technology Landscape 5th Edition, May 2017
2.02 MB
UNAIDS 2016 | GUIDANCE HIV prevention among adolescent girls and young women
399.20 KB
UNAIDS 2016. Intellectual property. Questions and answers
128.37 KB
UNAIDS DATA 2017
3.16 MB
UNAIDS financial outlook.
1.87 MB
UNAIDS report: AIDS data
1.12 MB
UNAIDS REPORT: AIDS DATA
1.12 MB
UNAIDS. Strategic investment.
198.33 KB
UNDP NGO factsheet Belarus.
1.44 MB
UNDP NGO factsheet Kyrgyzstan
1.38 MB
UNDP NGO factsheet Kyrgyzstan.
1.44 MB
UNDP NGO factsheet Moldova.
1.44 MB
UNDP NGO factsheet Tajikistan.
1.44 MB
UNDP NGO factsheet Tajikistan.
1.37 MB
UNDP NGO factsheet Ukraine.
1.44 MB
UNDP NGO factsheet Uzbekistan.
1.50 MB
UNITAID contribution to scale-up access to ART towards the 90.90.90 targets.
1.28 MB
UNODC drugs. Country fact sheets.
9.88 MB
Update on PQ programme and regional harmonization of drug registration 2015.
1.12 MB
Updates on hepatitis B and C treatment.
2.57 MB
WHEN WOMEN LEAD CHANGE HAPPENS. Women advancing the end of AIDS.
1.22 MB
WHO consolidated guidelines on HIV testing services. What you need to know.
1.54 MB
WHO Global hepatitis report, 2017
2.45 MB
WHO global survey on ARV and diagnostic use in 2014 in low _ middle-income countries.
529.17 KB
WHO Guidelines for the managing advanced HIV disease and rapid initiation of antiretroviral therapy. July 2017
4.14 MB
WHO increasing access to HIV treatment in middle-income countries. Key data on prices, regulatory status, tariffs and the intellectual property situation
3.12 MB
WHO recommends assistance for people with HIV to notify their partners Policy brief
1.26 MB
WHO recommends HIV testing by lay providers. 2015.
415.77 KB
WHO regional technical consultation on the dissemination of consolidated guidelines on HIV testing services. 2016.
1.18 MB
WHO treatment guidelines for drug-resistant tuberculosis. 2016 update.
1.24 MB
WHO update on CADOPADO what are the challenges in using the current guidelines and foreseen ARV revisions opportunities and challenges.
2.90 MB
WHO. MhGAP intervention guide for mental, neurological and substance use disorders in non-specialized health settings.
1.89 MB
Women, drugs and HIV.
107.06 KB
Women, harm reduction, and HIV. Key findings from Azerbaijan, Georgia, Kyrgyzstan, Russia, and Ukraine.
326.34 KB
World Drug Report 2017. Part 1. EXECUTIVE SUMMARY CONCLUSIONS AND POLICY IMPLICATIONS
4.16 MB
World Drug Report 2017. Part 2. GLOBAL OVERVIEW OF DRUG DEMAND AND SUPPLY Latest trends, cross-cutting issues
2.22 MB
World Drug Report 2017. Part 3. MARKET ANALYSIS OF PLANT-BASED DRUGS Opiates, cocaine, cannabis
540.73 KB
World Drug Report 2017. Part 4. MARKET ANALYSIS OF SYNTHETIC DRUGS Amphetamine-type stimulants, new psychoactive substances
1.71 MB
World Drug Report 2017. Part 5. THE DRUG PROBLEM AND ORGANIZED CRIME, ILLICIT FINANCIAL FLOWS, CORRUPTION AND TERRORISM
1.95 MB
АРТ в картинках: доступно о лечении ВИЧ
1.33 MB
Ведення побічних реакцій під час лікування хворих на туберкульоз та ко-інфекцію (Ттуберкульоз/ВІЛ-Іінфекція/СНІД). Методичний посібник для лікарів.
320.27 KB
ВИЧ 2014/15 Под редакцией Кристиана Хоффмана и Юргена К. Рокштро
13.94 MB
ВИЧ и инструмент оценки социальной защиты. ЮНЭЙДС 2017 | CПРАВОЧНЫЙ МАТЕРИАЛ
1.11 MB
Влияние наркополитики на женщин.
388.81 KB
Глобальный мониторинг эпидемии СПИДа 2017
1.05 MB
Дослідження “Обізнаність населення про епідемію ВІЛ в Україні 2016”
1.48 MB
Женщины и ВИЧ в странах ВЕЦА. Отчет по результатам онлайн-анкетирования НП «Е.В.А.».
631.35 KB
Женщины, снижение вреда и ВИЧ. Ключевые выводы исследований в Азербайджане, Грузии, Кыргызстане, России и Украине.
1.73 MB
Имплементация гибких положений ТРИПС с целью расширения доступа к лекарственным средствам в Беларуси, Грузии, Молдове и Украине.
1.25 MB
Инвестирование в ответы сообществ: кейс для финансирования не-сервисных активностей сообщества для победы над СПИДом
623.75 KB
Интеграция совместного оказания услуг в связи с ТБ и ВИЧ во всеобъемлющий пакет помощи для потребителей инъекционных наркотиков.
1.28 MB
Информационный бюллетень “Возможности участия гражданского общества и сообществ в процессах выделения грантов Глобального фонда”
906.10 KB
Каскад лечения ВИЧ. Стратегии, инструменты и линии поведения для того, чтобы получить лучшее лечение ВИЧ для большего количества людей и быстрее.
2.22 MB
Клинический протокол «Диагностика и лечение пациентов с ВИЧ-инфекцией» в Республике Беларусь
218.65 KB
Методические рекомендации по доступу к бюджетным средствам для СО НКО, работающих в сфере профилактики и предупреждения распостранения ВИЧ-инфекции, а также работающих с людьми, живущими с ВИЧ
962.12 KB
НАЦИОНАЛЬНЫЙ ПЛАН ДЕЙСТВИЙ СООБЩЕСТВ ЭСТОНИИ
1.34 MB
Новостной дайджест Эстонского Консорциума Сообществ – 06. 2017
5.05 MB
Нормативно-правовая база по антиретровирусным препаратам и терапии в отдельных странах СНГ. Аналитический отчет.
3.50 MB
Отчет “Гепатит В и С в регионе Восточной Европы и Центральной Азии: эпидемия и ответные меры”
1.14 MB
План действий по борьбе с туберкулезом для Европейского региона ВОЗ на 2016–2020 гг.
963.00 KB
ПОВЕСТКА ДНЯ 2030 г. по вопросам здоровья и благополучия ЛГБТ Июль 2017 г
285.28 KB
Практические рекомендации по использованию новой модели финансирования для удовлетворения потребностей сообществ
613.56 KB
Практический инструмент по адвокации увеличения государственного бюджета на программы лечения ВИЧ-инфекции
556.83 KB
Практическое руководство для выздоравливающих. Что такое туберкулез.
636.18 KB
Провал правосудия. Насилие над секс-работниками со стороны государства и частных лиц — в поисках правосудия и безопасности.
713.38 KB
ПРОГРАММА «НЕПРАВИТЕЛЬСТВЕННЫЕ ОРГАНИЗАЦИИ» Представительство ЕС в России, 2016
59.45 MB
Профилактика, диагностика, лечение и уход в связи с ВИЧ- инфекцией для ключевых групп населения.
4.16 MB
Региональный план действий сообществ по расширению устойчивого доступа к качественной и непрерывной помощи при ВИЧ-инфекции для всех, кто в этом нуждается, в регионе Восточной Европы и Центральной Азии
1.74 MB
Резервные препараты под микроскопом. Противотуберкулезные средства: Источники и цены. 4-ое издание, март 2016
0.00 KB
Рекомендации Европейского клинического общества СПИДа 2016 года
1.19 MB
Рекомендации Европейского клинического общества СПИДа Версия 8.1 Октябрь 2016
1.19 MB
Руководство для сообществ: составление регионального альтернативного отчета по ВИЧ/СПИДу и ТБ
863.22 KB
СВОДНОЕ РУКОВОДСТВО ПО ИСПОЛЬЗОВАНИЮ АНТИРЕТРОВИРУСНЫХ ПРЕПАРАТОВ ДЛЯ ЛЕЧЕНИЯ И ПРОФИЛАКТИКИ ВИЧ-ИНФЕКЦИИ
15.84 MB
Сводное руководство по использованию антиретровирусных препаратов для лечения и профилактики ВИЧ-инфекции.
32.56 MB
Стратегический план AAE на 2015-2017гг.: Преемственность и новаторство – на пути к более эффективным мерам в ответ на эпидемию ВИЧ
3.95 MB
Стратегия ЮНЭЙДС на 2016-2021 гг. Ускорение мер для прекращения эпидемии СПИДа
5.49 MB
Уход и поддержка при ВИЧ- инфекции в контексте Сводного руководства ВОЗ 2016 г.
2.96 MB